| INTRODUC TI ON
DOCK8 immunodeficiency syndrome (DIDS), sometimes termed DOCK8 deficiency, has been previously reviewed elsewhere. [1] [2] [3] DIDS is a combined immunodeficiency that has several unusual clinical features (see pictorial summary in Figure 1A ). Most but not all cases of DIDS are associated with elevated serum IgE. Because of this, the disease was initially referred to as an autosomal recessive hyperimmunoglobulinemia E syndrome (AR-HIES) due to its clinical resemblance to autosomal dominant (AD)-HIES. 4 
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of UDP-N-acetylglucosamine, a required building block for both Nand O-linked glycosylation. [5] [6] [7] Compared to DIDS, autoimmunity, neurocognitive defects, neutropenia, and skeletal abnormalities are prominent or unique features to PGM3 deficiency. Recently, ZNF341 deficiency was reported to impair STAT3 transcription and autoinduction through the lack of this transcription factor, which normally binds to the STAT3 promoter. 8, 9 As expected, this leads to an AD-HIES phenocopy, but not the severe life-threatening allergies or intractable virus infections of the skin that are characteristic of DIDS. Although TYK2 deficiency was initially reported as a form of AR-HIES, follow-up studies in more patients revealed that susceptibility to mycobacteria and viruses were characteristic features but not elevated serum IgE or severe allergies. 10 Other immunodeficiencies such as the Wiskott-Aldrich syndrome, Omenn syndrome, and IPEX syndrome can also present sporadically with features similar to DIDS including elevated serum IgE.
Patients found retrospectively to have DIDS have been followed longitudinally at the NIH Clinical Center since the 1980s. To date, a total of 53 patients spanning ages from 6 months to 43 years old have been evaluated and followed here by us. These patients have been studied on research protocols that focus on the natural history of this disease, basic science investigations into pathogenic mechanisms, and optimizing treatment including hematopoietic stem cell transplantation.
| G ENE TI C BA S IS OF D IS E A S E
The Human Genome Project, International HapMap Project, and 1000 Genomes Project led to the appreciation that considerable variation among individual human genomes derives from structural variations, rather than single nucleotide polymorphisms. 11 Thus, we reasoned that structural variations might contribute to monogenic disorders of immunity, and that technological improvements in detecting structural variants could reveal new genetic causes of disease in some patients. To test this hypothesis, we performed comparative genomic hybridization arrays, which allows for the unbiased detection of large deletions and duplications, in patients with AR-HIES. This approach revealed large homozygous or compound heterozygous deletions in the DOCK8 gene in affected patients but not in their unaffected family members. 12 Around the same time, other groups used homozygosity mapping with sequencing of shared regions to identify autosomal recessive mutations in DOCK8 in different cohorts of AR-HIES patients. (1), dendritic cells normally take up antigen and travel through the afferent lymphatics (2) to the lymph node where they prime T cells (3) . Responding T cells differentiate and travel through efferent lymphatics to the blood, where they exit through venules into various tissues including the dermis of the skin. In DIDS, (2) and hence (3) are defective; additionally, T H 1-differentiated cells are decreased, T H 2-differentiated cells are increased, and T H 17-differentiated cells are decreased (4) . Differentiated T cells extravasate into the skin where the cytokine imbalances contribute to increased virus replication (5), atopic dermatitis (6), and mucocutaneous candidiasis (7), respectively. In parallel, tissue resident memory T cells (T RM ) or NK cells normally kill virus-infected cells as they migrate continuously within the epidermis (7). In DIDS, these migrating cells undergo a form of cell death called cytothripsis, which compromises local antiviral immunity, also leading to increased virus replication (5) One interesting aspect of the molecular etiology of DIDS is that large deletions affecting the DOCK8 gene are frequently observed. In our NIH cohort of DIDS patients, approximately 62% of unrelated patients had at least one large deletion on one or both alleles ( Table 1 
| VIRUS INFEC TI ON S OF THE S K IN
As mentioned above, DIDS is characterized by chronic virus infections that have a predilection for the skin. 17 The viruses responsible are herpes simplex virus, varicella-zoster virus, human papillomavirus, and molluscum contagiosum virus. These DNA viruses are commonly encountered in the general population during childhood, when most of these viruses establish latent infections following initial infection. In DIDS, initial virus infections are not usually very severe. Rather, the viral rashes never clear or become persistent after reactivation from latency. Over time, but especially evident starting in early adolescence, the infections extend over larger areas of skin as the disease progresses.
In DIDS, the herpes simplex virus infections involve the skin or oral mucosal surfaces and can eventually cause keratitis or even contribute to periodontitis. 18 These infections are often ulcerating and difficult to control, and their chronicity can lead to acyclovir resis- Of historical note, unlike the other viruses, which normally establish latent infections in the healthy host, molluscum contagiosum virus causes an acute infection characterized by scattered skin lesions that typically resolve after few months. For this reason and an inability to culture the virus, the molluscum contagiosum virus genome was only sequenced after isolation from a DIDS patient carrying a high burden of such skin lesions (Steve Holland, personal communication). 22 Because of the high burden of virus skin lesions, DIDS patients have also been useful in skin virome studies that have uncovered new strains of human papillomavirus. 23 Our clinical observations of unusually severe virus infections of the skin in DIDS patients can be reproduced using models of experimental virus infections in mice. Although mice cannot be infected with human papillomavirus, molluscum contagiosum virus, or varicella-zoster virus, they are susceptible to herpes simplex virus. As predicted from our clinical observations of the patients, epicutaneous infections with herpes simplex virus lead to increased disease severity and lethality in mice genetically lacking Dock8. 24 Subsequent studies by a different group similarly showed increased susceptibility of different Dock8-deficient mouse strains to herpes simplex virus infections.
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We next asked what accounted for this localized infection susceptibility. At the time of our discovery of the genetic basis of this disease, little was known regarding the normal functions of DOCK8.
DOCK8 is a member of the DOCK (Dedicator of Cytokinesis) family of atypical guanine-nucleotide exchange factors that promote activation of the small RHO family GTPase CDC42. Because CDC42
is important for biological processes that involve cytoskeletal rearrangement, we hypothesized that loss of DOCK8, by impairing activation of CDC42, could cause abnormal immune cell trafficking in the skin. To test this, we first examined the behavior of T cells and NK cells, which are important for killing virus-infected cells, in a skin-like microenvironment. DOCK8-deficient cells were allowed to enter into a skin sample or were placed inside a high-concentration collagen gel. Among tissues, skin has by far the highest collagen content; this component contributes structurally to a dense lattice made up by many highly confined spaces, which artificially mimics the skin's dermal collagen bundles and epidermal tight junctions.
Microscopic imaging in such skin-like microenvironments revealed that the DOCK8-deficient lymphocytes adopt an abnormally elongated shape with deformed nucleus as they randomly move. 24 These cells can migrate normally toward a chemokine gradient, but over a period of hours they eventually catastrophically break up into small pieces in an unusual form of cell death called cytothripsis (for "cell shattering") ( Figure 1B 
| OTHER VIRUS INFEC TI ON S
DIDS patients can have detectable Epstein-Barr virus (EBV) in the peripheral blood, with levels typically not more than several tens of thousands of genome copies/mL. In our cohort at the NIH, of 44 who
had EBV PCR in blood tested, 16 were viremic (36%). No patients were known to be EBV-infected without detectable blood PCR.
However, in patients who had no detectable EBV PCR, many were on immune globulin replacement so their EBV-naive status could not be confirmed. DIDS patients infected with EBV do not experience fulminant infectious mononucleosis, but the increased virus burden probably contributes to the development of EBV-associated lymphomas and lymphoproliferative disease, 29 which can be the first grossly obvious manifestation of DIDS. In contrast, systemic cytomegalovirus (CMV) infection, with detectable virus in the blood along with retinitis and meningitis, has been reported in only a few DIDS patients. Within the NIH cohort, we have seen CMV viremia but without signs of CMV disease. CMV disease seems to correlate with increased morbidity and mortality in DIDS patients. 13 Similarly, a few DIDS patients have also developed progressive multifocal leu- Additional studies are needed to determine whether loss of DOCK8 in macrophages also affects other processes such as phagocytosis.
However, together the current literature suggests complex effects on macrophages, which might explain the lack of a net susceptibility to macrophage-sensitive pathogens.
| VA SCULOPATHY
Vasculopathy or vasculitis affects middle-and large-sized blood vessels in a subset of DIDS patients. In our cohort at the NIH, ap- Vasculopathy can occur at other sites, for example renal artery stenosis, which was discovered in one DIDS patient during workup for hypertension, 56 or celiac artery aneurysm with stenosis and thrombosis in another DIDS patient. 
| ALLERG I C D IS E A S E
By definition, HIES patients have eczematous dermatitis and most have high levels of IgE in the serum. However, the presence of allergen-specific IgE does not necessarily mean that the patients have severe allergic disease. For example, AD-HIES patients have no or minimal allergic disease because they lack functional STAT3 in mast cells, which is required for degranulation and histamine release. 65 In contrast, most DIDS patients have asthma and food allergies, with prevalences in our cohort of 53% and 55%, respectively; these are greater than the estimated prevalences of up to approximately 10% and 5%, respectively, in the general population. 66 The increased prevalence of asthma in DIDS patients can be recapitulated in a Dock8-deficient mouse model, which shows increased airway hyperreactivity following antigen-sensitization in the airway. 67 While the atopic dermatitis in DIDS patients is variably severe, the allergic rhinitis and asthma are milder, and are adequately controlled by medication without need for allergen immunotherapy. In contrast, food allergies are especially severe in DIDS patients who often are allergic to multiple foods and have had life-threatening anaphylaxis.
Moreover, some DIDS patients also develop eosinophilic esophagitis, a type of chronic allergic inflammation. 12 It is the severity of food allergies that is particularly distinctive of DIDS, in comparison to other genetically defined HIES or combined immunodeficiencies. 
| AUTOIMMUNIT Y
Generally, immunodeficiencies with partial defects in T cell function can be associated with autoimmune disease. In a retrospective analysis of 136 DIDS patients, autoimmunity was reported in 13%, with nearly half attributed to vasculitis, a third due to autoimmune hemolytic anemia, and 6% to nephropathy. 40 whether autoimmunity can also be cured. However, food allergies remain a significant problem for many patients, 88 an observation that has been replicated in a larger retrospective review of transplanted DIDS patients. 89 Because donor chimerism in the bone marrow, as compared to peripheral blood, can be incomplete, 88 It is likely that the conditioning regimens used do not fully eliminate long-lived plasma cells that continue to produce food allergen-specific IgE after transplant. However, since total IgE gradually decreases after transplant, 88 food allergen-specific IgE might also gradually decrease so that these food allergies could eventually resolve. Similarly, the continued presence of long-lived autoimmune plasma cells might mean that patients could continue to have autoimmune disease even after the transplant. However, it is also possible that reconstitution of DOCK8-replete donor T reg cells might suppress autoimmune plasma cells and improve if not cure autoimmune disease in DIDS.
| C AN CER

| TR AN S PL ANTATI ON
Long-term outcome studies in more DIDS patients will help to shed light on these questions. Our work has established that DOCK8 is crucial for regulating the shape and integrity of lymphocytes, particularly of antiviral resident memory CD8 + T cells, as they maneuver through the skin. In DIDS patients, the localized lymphocyte survival defect might also contribute to other skin disease such as the atopic dermatitis, mucocutaneous candidiasis, and skin cancers, as well as the vasculopathy, which can be associated with varicella-zoster virus reactivation.
| CON CLUS IONS
Additional studies to delineate the biochemical pathway affected may generate useful knowledge for overcoming this defect.
Finally, besides being a combined immunodeficiency, which can sometimes be associated with increased IgE, DIDS can also be viewed as a hyper-IgE syndrome, due the markedly high levels of serum IgE and even greater frequency and severity of allergic disease than other hyper-IgE syndromes. This disease feature results from T H 2 skewing with eosinophilia, as well as abnormal regulation of isotype switching, although a possible connection to alterations in cytoskeleton and cell survival has not been investigated. Biochemical studies supporting a physical association of DOCK8 with STAT3 under certain circumstances for optimal signaling in some immune cell types are intriguing, as they suggest a possible mechanistic link to other forms of hyper-IgE syndrome. Future studies to decipher the molecular underpinnings of DIDS that point to the similarities and differences to these related diseases will be informative.
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